HomeCompareVIMGF vs EQR

VIMGF vs EQR: Dividend Comparison 2026

VIMGF yields 72.20% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VIMGF wins by $1.12M in total portfolio value
10 years
VIMGF
VIMGF
● Live price
72.20%
Share price
$2.77
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.16M
Annual income
$312,669.66
Full VIMGF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — VIMGF vs EQR

📍 VIMGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVIMGFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VIMGF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VIMGF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIMGF
Annual income on $10K today (after 15% tax)
$6,137.18/yr
After 10yr DRIP, annual income (after tax)
$265,769.21/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, VIMGF beats the other by $261,114.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIMGF + EQR for your $10,000?

VIMGF: 50%EQR: 50%
100% EQR50/50100% VIMGF
Portfolio after 10yr
$606.2K
Annual income
$159,072.63/yr
Blended yield
26.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

VIMGF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$42.00
+1416.2% upside vs current
Range: $42.00 — $42.00
Altman Z
2.8
Piotroski
6/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIMGF buys
0
EQR buys
0
No recent congressional trades found for VIMGF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVIMGFEQR
Forward yield72.20%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1.16M$47.8K
Annual income after 10y$312,669.66$5,475.61
Total dividends collected$996.9K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$42.00$70.35

Year-by-year: VIMGF vs EQR ($10,000, DRIP)

YearVIMGF PortfolioVIMGF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$17,920$7,220.22$11,380$679.82+$6.5KVIMGF
2$31,267$12,092.32$13,014$837.25+$18.3KVIMGF
3$53,174$19,718.24$14,961$1,036.20+$38.2KVIMGF
4$88,236$31,339.88$17,297$1,289.22+$70.9KVIMGF
5$143,015$48,602.72$20,121$1,613.15+$122.9KVIMGF
6$226,649$73,622.99$23,561$2,030.84+$203.1KVIMGF
7$351,559$109,044.01$27,783$2,573.54+$323.8KVIMGF
8$534,242$158,074.42$33,013$3,284.39+$501.2KVIMGF
9$796,140$224,500.96$39,547$4,223.51+$756.6KVIMGF
10$1,164,540$312,669.66$47,791$5,475.61+$1.12MVIMGF

VIMGF vs EQR: Complete Analysis 2026

VIMGFStock

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. The company was incorporated in 2020 and is headquartered in Stockholm, Sweden.

Full VIMGF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this VIMGF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIMGF vs SCHDVIMGF vs JEPIVIMGF vs OVIMGF vs KOVIMGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.